• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于未经证实但高度怀疑为I期肺癌的肺肿瘤, upfront手术的潜在生存获益 。

Potential Survival Benefit of Upfront Surgery for Lung Tumors Unconfirmed but Highly Suspicious for Stage I Lung Cancer.

作者信息

Kara Murat, Erdogdu Eren, Duman Salih, Fatalizade Gulnar, Ozkan Berker, Toker Alper

机构信息

Department of Thoracic Surgery, Istanbul University Medical Faculty, Istanbul, Turkey.

Department of Cardiovascular and Thoracic Surgery, West Virginia University Heart and Vascular Institute, Morgantown, WV, USA.

出版信息

J Chest Surg. 2024 Sep 5;57(5):440-446. doi: 10.5090/jcs.23.166. Epub 2024 Jun 5.

DOI:10.5090/jcs.23.166
PMID:38835210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11392711/
Abstract

BACKGROUND

Patients with early-stage lung tumors that are highly suspicious for malignancy typically undergo a preoperative diagnostic workup, primarily through bronchoscopy or transthoracic biopsy. Those without a preoperative diagnosis may alternatively be treated with upfront surgery, contingent upon the potential for intraoperative diagnosis. Previous studies have yielded conflicting results regarding the impact of upfront surgery on the survival of these patients. Our study aimed to elucidate the effect of upfront surgery on the survival outcomes of patients undergoing surgery for early-stage lung cancer without a preoperative diagnosis.

METHODS

We analyzed the survival rate of 158 consecutive patients who underwent pulmonary resection for stage I lung cancer, either with or without a preoperative diagnosis.

RESULTS

A total of 86 patients (54%) underwent upfront surgery. This approach positively impacted both disease-free survival (p=0.031) and overall survival (p=0.017). However, no significant differences were observed across subgroups based on sex, smoking status, forced expiratory volume in 1 second, histologic tumor size, or histologic subtype. Univariate analysis identified upfront surgery (p=0.020), age (p=0.002), maximum standardized uptake value (SUVmax) exceeding 7 (p=0.001), and histological tumor size greater than 20 mm (p=0.009) as independent predictors. However, multivariate analysis indicated that only SUVmax greater than 7 (p=0.011) was a significant predictor of unfavorable survival.

CONCLUSION

Upfront surgery does not appear to confer a survival advantage in patients with stage I lung cancer undergoing surgical intervention.

摘要

背景

早期肺部肿瘤高度怀疑为恶性的患者通常会接受术前诊断检查,主要通过支气管镜检查或经胸活检。那些没有术前诊断的患者可选择直接进行手术,但取决于术中诊断的可能性。先前的研究对于直接手术对这些患者生存的影响得出了相互矛盾的结果。我们的研究旨在阐明直接手术对未进行术前诊断的早期肺癌手术患者生存结局的影响。

方法

我们分析了158例连续接受I期肺癌肺切除术的患者的生存率,这些患者有或没有术前诊断。

结果

共有86例患者(54%)接受了直接手术。这种方法对无病生存率(p=0.031)和总生存率(p=0.017)均有积极影响。然而,在性别、吸烟状况、一秒用力呼气量、组织学肿瘤大小或组织学亚型等亚组中未观察到显著差异。单因素分析确定直接手术(p=0.020)、年龄(p=0.002)、最大标准化摄取值(SUVmax)超过7(p=0.001)和组织学肿瘤大小大于20 mm(p=0.009)为独立预测因素。然而,多因素分析表明,只有SUVmax大于7(p=0.011)是生存不良的显著预测因素。

结论

对于接受手术干预的I期肺癌患者,直接手术似乎并未带来生存优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/c43d87314a4c/jcs-57-5-440-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/5b2a736a515f/jcs-57-5-440-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/9f78023e85b7/jcs-57-5-440-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/c43d87314a4c/jcs-57-5-440-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/5b2a736a515f/jcs-57-5-440-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/9f78023e85b7/jcs-57-5-440-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe32/11392711/c43d87314a4c/jcs-57-5-440-f3.jpg

相似文献

1
Potential Survival Benefit of Upfront Surgery for Lung Tumors Unconfirmed but Highly Suspicious for Stage I Lung Cancer.对于未经证实但高度怀疑为I期肺癌的肺肿瘤, upfront手术的潜在生存获益 。
J Chest Surg. 2024 Sep 5;57(5):440-446. doi: 10.5090/jcs.23.166. Epub 2024 Jun 5.
2
Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.临床III期食管鳞状细胞癌患者新辅助化疗与先行手术加或不加化疗的比较。
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12473.
3
Intraoperative conversion during video-assisted thoracoscopy resection for lung cancer does not alter survival.电视辅助胸腔镜肺癌切除术中转开胸并不影响生存率。
Interact Cardiovasc Thorac Surg. 2021 Jun 28;33(1):68-75. doi: 10.1093/icvts/ivab044.
4
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.使用自我报告的身体功能评估,比较电视辅助胸腔镜肺叶切除术与开胸肺叶切除术治疗肺癌对恢复的影响:VIOLET RCT。
Health Technol Assess. 2022 Dec;26(48):1-162. doi: 10.3310/THBQ1793.
5
Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.基于容积的18F-FDG PET/CT评估改善ⅢA-N2期非小细胞肺癌患者的预后预测
AJR Am J Roentgenol. 2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847.
6
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
7
Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.新辅助化疗与 upfront 手术治疗 IIIA 期非小细胞肺癌患者纵隔淋巴结状态和复发模式的比较:单中心经验。
Thorac Cancer. 2017 Sep;8(5):393-401. doi: 10.1111/1759-7714.12447. Epub 2017 Jul 3.
8
Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial.当前和既往吸烟状态对初始手术治疗非转移性非小细胞肺癌结局的影响;国家肺癌筛查试验的结果。
Expert Rev Respir Med. 2019 Jun;13(6):585-591. doi: 10.1080/17476348.2019.1615887. Epub 2019 May 15.
9
[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with 
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].[PET/CT最大标准摄取值在可切除肺鳞状细胞癌预后中的作用分析及其与临床病理特征的相关性]
Zhongguo Fei Ai Za Zhi. 2016 Apr 20;19(4):192-9. doi: 10.3779/j.issn.1009-3419.2016.04.03.
10
Primary tumor standardized uptake value (SUVmax) measured on F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer.F-FDG PET/CT 测量的原发肿瘤标准化摄取值(SUVmax)和混合非小细胞肺癌成分可预测手术切除的小细胞肺癌合并症的生存。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2595-2605. doi: 10.1007/s00432-020-03240-8. Epub 2020 Jun 3.

引用本文的文献

1
Commentary: Preoperative versus Intraoperative Tissue Diagnosis in Highly Suspicious Stage I Lung Cancer: Which Is the Superior Approach?评论:高度可疑的Ⅰ期肺癌术前与术中组织诊断:哪种方法更优?
J Chest Surg. 2024 Sep 5;57(5):447-449. doi: 10.5090/jcs.24.074. Epub 2024 Aug 8.

本文引用的文献

1
Clinical Outcomes after Upfront Surgery in Clinical Stage I-IIA Small Cell Lung Cancer.临床I-IIA期小细胞肺癌 upfront 手术后的临床结局
J Chest Surg. 2022 Dec 5;55(6):470-477. doi: 10.5090/jcs.22.085.
2
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌,2022年第3版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2022 May;20(5):497-530. doi: 10.6004/jnccn.2022.0025.
3
Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study.
荷兰先进非小细胞肺癌患者治疗时间对生存的影响:一项全国性观察队列研究。
Thorax. 2023 May;78(5):467-475. doi: 10.1136/thoraxjnl-2021-218059. Epub 2022 Apr 21.
4
Prognostic factors, treatment, and outcomes in combined small cell lung cancer: a SEER survey from 2004 to 2015.小细胞肺癌合并症的预后因素、治疗及结果:一项2004年至2015年的监测、流行病学和结果(SEER)调查
Transl Cancer Res. 2020 Sep;9(9):5292-5303. doi: 10.21037/tcr-20-968.
5
Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival.评估 I 期非小细胞肺癌手术延迟对生存的影响。
Ann Surg. 2021 May 1;273(5):850-857. doi: 10.1097/SLA.0000000000004811.
6
Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm.术前经支气管肺活检对直径小于 3cm 的非小细胞肺癌的影响。
In Vivo. 2021 Mar-Apr;35(2):1027-1031. doi: 10.21873/invivo.12346.
7
Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.诊断至非小细胞肺癌治疗时间间隔对生存的影响:台湾的全国队列研究。
BMJ Open. 2020 Apr 22;10(4):e034351. doi: 10.1136/bmjopen-2019-034351.
8
Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer.术前活检不影响可切除非小细胞肺癌的术后结局。
Gen Thorac Cardiovasc Surg. 2019 Jul;67(7):615-623. doi: 10.1007/s11748-019-01062-1. Epub 2019 Jan 18.
9
Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer.术前支气管镜检查确诊癌症并不会增加ⅠA期非小细胞肺癌的复发风险。
Gen Thorac Cardiovasc Surg. 2018 May;66(5):284-290. doi: 10.1007/s11748-018-0909-y. Epub 2018 Mar 21.
10
Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons.在没有术前组织诊断的情况下对可疑肺部肿块进行手术:利弊。
Eur J Cardiothorac Surg. 2013 Aug;44(2):231-7; discussion 237. doi: 10.1093/ejcts/ezs671. Epub 2013 Jan 8.